Background: Delusions are defined as false beliefs different from those that almost everyone else believes. The aim was to develop a new measure (the Cardiff Beliefs Questionnaire, CBQ) to establish the range and prevalence of delusion-like beliefs (DLB) and compare these to other types of beliefs in the general population. Sampling and Methods: A total of 1,000 participants completed the CBQ, which uniquely assesses a broader range of currently held beliefs [delusion-like (bizarre and non-bizarre), paranormal and religious and general political/social beliefs) using this large stratified sample. Results: Strong belief in 1 or more DLB was reported by 39% of the participants (91% reporting ‘weak’, ‘moderate’ or ‘strong’ belief in at least 1 DLB). Moreover, 25% endorsed at least 1 bizarre DLB (76% one or more at any strength). Endorsements of DLB were strongly correlated with paranormal and religious beliefs but not general political/social beliefs. Conclusions: Both bizarre and non-bizarre DLB are frequently found in the general population, lending support to the psychosis continuum account and need to revise key clinical criteria used to diagnose delusions. The good psychometric properties demonstrated by the CBQ indicate that this measure is a useful tool to investigate the wider continuum of beliefs held in the general population.

Keywords:
Delusion-like belief, Paranormal belief, Religious belief, Continuum
This content is only available via PDF.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.